The pre-clinical absorption, distribution, metabolism and excretion properties of IPI-926, an orally bioavailable antagonist of the hedgehog signal transduction pathway
2005 ◽
Vol 1
(3)
◽
pp. 277-288
◽
2012 ◽
Vol 132
(7)
◽
pp. 1516-1524
◽
2014 ◽
Vol 147
(1)
◽
pp. 508-516
◽
1998 ◽
Vol 5
(1)
◽
pp. 39A-39A